ARTL
Artelo Biosciences, Inc.
There isn't enough reported data to score ARTL yet.
ARTL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ARTL's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
ARTL PE Valuation
ARTL has no meaningful PE right now: it lost money over the past year.
ARTL Forward outlook
There aren't enough analyst estimates for ARTL to show an outlook.
ARTL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$107.14 | +$458.82 |
| Q2 2026 | -$211.14 | +$304.33 |
| Q1 2026 | -$354.60 | +$131.52 |
| Q4 2025 | -$435.24 | +$58.86 |
| Q3 2022 | -$676.37 | +$295.63 |
| Q4 2021 | -$826.20 | +$1,603.80 |
| Q3 2021 | -$972.00 | +$2,089.80 |
| Q2 2021 | -$1,312.20 | +$3,645.00 |
ARTL is still losing money, but far less than before: $107.14 per share over the past year, against $5,273.10 at its worst in early 2020.
ARTL Quarterly Revenue
ARTL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.6M | +$873K |
| Q2 2026 | -$5M | -$4.5M |
| Q1 2026 | -$1.2M | +$406K |
| Q4 2025 | -$2.9M | -$344K |
| Q3 2025 | -$3.5M | -$2.7M |
| Q2 2025 | -$514K | +$1.5M |
| Q1 2025 | -$1.6M | +$1.3M |
| Q4 2024 | -$2.6M | +$29K |
ARTL has burned cash in almost every quarter: −$12M over the past year, against −$8M the year before.
ARTL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +84% | +253K shares |
| 1 year | +2507% | +533K shares |
| 3 years | +3011% | +536K shares |
| 5 years | +13079% | +550K shares |
ARTL has 554,197 diluted shares, up 2507% from a year ago.
ARTL Net Leverage
ARTL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARTL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 0.9 | Oversold |
ARTL's weekly RSI is 33 (neutral) and its Stochastic is 1 (oversold).
ARTL PE vs Healthcare Sector
ARTL has no meaningful PE right now: it lost money over the past year.
ARTL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.87 | 27% below |
| 20 week MA | $5.52 | 62% below |
| 50 week MA | $32.0 | 93% below |
| 100 week MA | $115.7 | 98% below |
| 200 week MA | $202.8 | 99% below |
ARTL is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
ARTL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,974.1 | $1,579.5 | -77% |
| 2021 | $1,579.5 | $1,458.0 | -7.7% |
| 2022 | $1,458.0 | $469.8 | -68% |
| 2023 | $469.8 | $226.8 | -52% |
| 2024 | $226.8 | $171.7 | -24% |
| 2025 | $171.7 | $40.2 | -77% |
| 2026 YTD | $40.2 | $2.10 | -95% |
ARTL has finished every year since 2020 lower, and it's down 95% so far in 2026.